Back to Search Start Over

Prion protein codon 129 polymorphism in mild cognitive impairment and dementia: the Rotterdam Study

Authors :
Gennady V. Roshchupkin
Meike W. Vernooij
Shahzad Ahmad
Annemieke J.M. Rozemuller
Cornelia M. van Duijn
Thom S Lysen
Alis Heshmatollah
Mohammad Arfan Ikram
Najaf Amin
Hata Karamujić-Čomić
Epidemiology
Radiology & Nuclear Medicine
Medical Informatics
Pathology
Amsterdam Neuroscience - Neurodegeneration
Source :
Brain Communications, 2(1):30. Oxford University Press, Brain Communications, 2(1):fcaa030. Oxford University Press, Karamujić-Čomić, H, Ahmad, S, Lysen, T S, Heshmatollah, A, Roshchupkin, G V, Vernooij, M W, Rozemuller, A J M, Ikram, M A, Amin, N & van Duijn, C M 2020, ' Prion protein codon 129 polymorphism in mild cognitive impairment and dementia : the Rotterdam Study ', Brain Communications, vol. 2, no. 1, fcaa030 . https://doi.org/10.1093/braincomms/fcaa030, Brain Communications
Publication Year :
2020

Abstract

Creutzfeldt–Jakob disease is a rare, fatal, neurodegenerative disease caused by the accumulation of abnormally folded prion proteins. The common polymorphism at codon 129 (methionine/valine) in the prion protein (PRNP) gene is the most important determinant of genetic susceptibility. Homozygotes of either allele have a higher risk of sporadic Creutzfeldt–Jakob disease. Various studies suggest that this polymorphism is also involved in other forms of dementia. We studied the association between the codon 129 polymorphism of the PRNP gene and mild cognitive impairment in 3605 participants from the Rotterdam Study using logistic regression analyses. Subsequently, we studied the association between this polymorphism and incident dementia, including Alzheimer’s disease, in 11 070 participants using Cox proportional hazard models. Analyses were adjusted for age and sex. We found the prevalence of mild cognitive impairment to be higher for carriers of the methionine/methionine genotype (odds ratio, 1.40; 95% confidence interval, 1.11–1.78; P = 0.005) as well as for carriers of the valine/valine genotype (odds ratio, 1.37; 95% confidence interval, 0.96–1.97; P = 0.08). The codon 129 polymorphism was not associated with the risk of incident dementia or Alzheimer’s disease. In conclusion, we found a statistically significant higher prevalence of mild cognitive impairment in carriers of the methionine/methionine genotype in the codon 129 polymorphism of the PRNP gene within this population-based study. No associations were found between the codon 129 polymorphism and dementia or Alzheimer’s disease in the general population.<br />There is increasing interest in the role of the common polymorphism at codon 129 in the prion protein gene in neurodegenerative traits. We report a role of this polymorphism in mild cognitive impairment in the general population. However, no association was found with dementia.<br />Graphical Abstract Graphical Abstract

Details

Language :
English
ISSN :
26321297
Database :
OpenAIRE
Journal :
Brain Communications, 2(1):30. Oxford University Press, Brain Communications, 2(1):fcaa030. Oxford University Press, Karamujić-Čomić, H, Ahmad, S, Lysen, T S, Heshmatollah, A, Roshchupkin, G V, Vernooij, M W, Rozemuller, A J M, Ikram, M A, Amin, N & van Duijn, C M 2020, ' Prion protein codon 129 polymorphism in mild cognitive impairment and dementia : the Rotterdam Study ', Brain Communications, vol. 2, no. 1, fcaa030 . https://doi.org/10.1093/braincomms/fcaa030, Brain Communications
Accession number :
edsair.doi.dedup.....11c5d7bcfccc2d930d845ee7115e75b5
Full Text :
https://doi.org/10.1093/braincomms/fcaa030